EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease

Noor Ul Ain iD, Noffar Bar, Lilu Guo, Katherine Klinger, Punita Gupta, Atta Ur Rahman, Ruhua Yang, Yanhong Deng, Natalia Neparidze, Shiny Nair, Pramod K Mistry

American Journal of Hematology · 2026-09 · 101 (9) · 2197-2213

DOI: 10.1002/ajh.70407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 17.06.2026. Verfasst von Noor Ul Ain und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Gaucher Disease, Plasma Cells, Clonal Evolution. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanofi, Rare Lysosomal Disease Fellowship (NUA), Norwich University of the Arts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic antigenic stimulation is implicated in the pathogenesis of monoclonal gammopathy and multiple myeloma, yet longitudinal human evidence linking sustained antigen exposure to modifiable clonal plasma cell evolution remains limited. Gaucher disease (GD), caused by biallelic GBA1 pathogenic variants, is characterized by accumulation of glucosylsphingosine (LysoGL1), the direct antigenic target of GD‐associated clonal immunoglobulins and a pharmacologically suppressible stimulus. We conducted a longitudinal retrospective cohort study of 235 adults with GD (3628 person‐years; 2662 clinical visits), with incident‐only ascertainment from a confirmed gammopathy‐free baseline. Thirty‐one patients (13.2%) developed incident monoclonal gammopathy. GD conferred a ninefold excess risk relative to population expectations (SIR 9.04; 95% CI 5.79–13.45). Male sex independently increased hazard 3.3‐fold (HR 3.30; 95% CI 1.55–7.03; p < 0.01), mirroring the established male predominance of plasma cell dyscrasias. GD‐specific therapy, initiated solely for systemic disease indications, was associated with a dose‐dependent reduction in incident risk. In univariate Cox regression with age as the time scale, each additional therapy year conferred a 9% lower hazard (HR 0.91; 95% CI 0.88–0.94; p < 0.001), extending mean MGUS‐free time by 8.4 years between untreated and most‐treated quartiles. Cumulative therapy progressively suppressed circulating LysoGL1, with eliglustat achieving substantially deeper reduction than enzyme replacement therapy alone. Propensity score‐weighted analyses were directionally concordant (IPTW HR 0.19; 95% CI 0.11–0.30; p < 0.001). These findings establish GD as a tractable model of antigen‐driven oncogenesis—and provide a precedent for investigating whether therapeutic reduction of a defined antigenic stimulus can modify oncogenic trajectory in other chronic inflammatory states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gaucher DiseasePlasma CellsClonal EvolutionHumansMaleFemaleRetrospective StudiesMiddle AgedAdultAgedLongitudinal StudiesGlucosylceramidaseParaproteinemias

Substanzen

Glucosylceramidase

Autor:innen und Institutionen

  • Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Sanofi, Cambridge, Massachusetts, USA.
  • Division of Clinical Genetics, St Joseph University Medical Center, Paterson, New Jersey, USA.
  • Information Technology University, Lahore, Pakistan.
  • Yale School of Public Health, New Haven, Connecticut, USA.

ORCID-Profile: Noor Ul Ain

Förderung

  • Sanofi
  • Rare Lysosomal Disease Fellowship (NUA)
  • Norwich University of the Arts

Zitieren

APA

Ain, N. U., Bar, N., Guo, L., Klinger, K., Gupta, P., Rahman, A. U., Yang, R., Deng, Y., Neparidze, N., Nair, S., & Mistry, P. K. (2026). Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease. American Journal of Hematology, 101(9), 2197-2213. https://doi.org/10.1002/ajh.70407

Vancouver

Ain NU, Bar N, Guo L, Klinger K, Gupta P, Rahman AU, et al. Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease. American Journal of Hematology. 2026;101(9):2197-2213. doi:10.1002/ajh.70407

BibTeX
@article{Ain2026,
  author = {Ain, Noor Ul and Bar, Noffar and Guo, Lilu and Klinger, Katherine and Gupta, Punita and Rahman, Atta Ur and Yang, Ruhua and Deng, Yanhong and Neparidze, Natalia and Nair, Shiny and Mistry, Pramod K},
  title = {Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {9},
  pages = {2197--2213},
  doi = {10.1002/ajh.70407}
}
Kostenlos starten →